Literature DB >> 20831911

Combined peptides of human enterovirus 71 protect against virus infection in mice.

Jiang Ning Liu1, Wei Wang, Jian Ying Duo, Yi Hao, Chun Mei Ma, Wan Bo Li, Shu Zhu Lin, Xue Zhong Gao, Xiao Lin Liu, Yan Feng Xu, Wen-Bo Xu, Chuan Qin, Lian Feng Zhang.   

Abstract

Human enterovirus 71 (EV71) is a cause of hand, foot and mouth disease (HMFD) in children under 6 years old, and could cause serious neurological complications in some patients. Numerous large outbreaks of EV71 caused HMFD have occurred recently in Asia, especially in China. The cross-reactivity of EV71 with human brain tissue was observed and the cross-reactivity inducing regions were identified in previously study, which suggested that there were two regions in structural proteins of virus should be avoided in the vaccine. Six peptides without cross-reactivity were selected and combined into three vaccine candidates and applied in further evaluation in neonatal mice. The Vac6 comprising the peptides of P(70-159), P(140-249), P(324-443) and P(746-876) of the structural proteins could provide effective protection on pups against virus infection, as shown in viral copies detection and histopathology examination. Immunohistochemical staining results indicated that Vac6 had no cross-reactivity with human brain tissues. Our results suggested that Vac6 could have potential clinical value against EV71 epidemics caused mainly by C4 strains in the mainland of China. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831911     DOI: 10.1016/j.vaccine.2010.08.080

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

Review 1.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

2.  Expression and purification of enterovirus type 71 polyprotein P1 using Pichia pastoris system.

Authors:  Xue Han; Xiaoling Ying; Hao Huang; Shili Zhou; Qi Huang
Journal:  Virol Sin       Date:  2012-07-28       Impact factor: 4.327

3.  Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.

Authors:  Junliang Chang; Jingliang Li; Wei Wei; Xin Liu; Guanchen Liu; Jiaxin Yang; Wenyan Zhang; Xiao-Fang Yu
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

4.  Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.

Authors:  Xue Han; Xiao-ling Ying; Shi-li Zhou; Tao Han; Hao Huang; Qi Jin; Fan Yang; Qi-ying Sun; Xian-xun Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 6.  Production of EV71 vaccine candidates.

Authors:  Pele Chong; Shih-Yang Hsieh; Chia-Chyi Liu; Ai-Hsiang Chou; Jui-Yuan Chang; Suh-Chin Wu; Shih-Jen Liu; Yen-Hung Chow; Ih-Jen Su; Michel Klein
Journal:  Hum Vaccin Immunother       Date:  2012-09-19       Impact factor: 3.452

7.  Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.

Authors:  Tao Meng; Annasaheb B Kolpe; Tanja K Kiener; Vincent T K Chow; Jimmy Kwang
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

8.  Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.

Authors:  Xingui Tian; Xiaobo Su; Xiao Li; Haitao Li; Ting Li; Zhichao Zhou; Tianhua Zhong; Rong Zhou
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Immunological evaluation and comparison of different EV71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Jui-Yuan Chang; Shu-Pei Lien; Meng-Shin Guo; Hau-Pong Tasi; Kuang-Nan Hsiao; Shih-Jen Liu; Charles Sia; Suh-Chin Wu; Min-Shi Lee; Chia-Hsin Hsiao; Jen-Ren Wang; Yen-Hung Chow; Pele Chong
Journal:  Clin Dev Immunol       Date:  2012-09-12

10.  Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.

Authors:  Balraj Premanand; Mookkan Prabakaran; Tanja K Kiener; Jimmy Kwang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.